Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 10/20 | 0.84 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.68 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29625234 | 1.00 | SNCA (0.84) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL29214094 | 0.93 | SNCA (0.79) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL30867073 | 0.93 | SNCA (0.79) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL14571431 | 0.92 | SNCA (0.72) | SNCANOX1CAPN9CASP3MEN1 | |
| Dimethyl Sulfoxide SCHEMBL18398818 | 0.92 | SNCA (0.72) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL30769632 | 0.92 | SNCA (1.00) | SNCANOX1MEN1KMT2ANPC1 | |
| SCHEMBL239724 | 0.92 | SNCA (1.00) | SNCANOX1MEN1KMT2ANPC1 | |
| SCHEMBL26017582 | 0.90 | SNCA (0.70) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL13210525 | 0.90 | SNCA (0.70) | SNCANOX1CAPN9CASP3MEN1 | |
| SCHEMBL8226190 | 0.87 | SNCA (0.67) | SNCANOX1CAPN9CASP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447421-A | Synthesis method of 3, 7-bis- (dimethylamino) -phenothiazine | 上海沃凯生物技术有限公司 | 2024-01-26 | — | — | CN | claimed |
| US-10700295-B2 | Metal complexes | UEA ENTERPRISES LIMITED (GB) | 2020-06-30 | — | — | US | claimed |
| CN-109337681-B | Preparation method and application of sulfur-nitrogen co-doped carbon quantum dot | 南京工业大学 | 2020-05-08 | — | — | CN | claimed |
| US-20190131549-A1 | METAL COMPLEXES | UEA ENTERPRISES LIMITED (GB) | 2019-05-02 | — | — | US | claimed |
| CN-104119294-B | The preparation method of 3,7- diaminostilbene 0H- phenothiazine compounds | 维斯塔实验室有限公司 | 2018-10-30 | — | — | CN | claimed |
| EP-3350189-A1 | METAL COMPLEXES | UEA Enterprises Limited (GB) | 2018-07-25 | — | — | EP | claimed |
| WO-2017046572-A1 | METAL COMPLEXES | UNIVERSITY OF EAST ANGLIA (GB) | 2017-03-23 | — | — | WO | claimed |
| US-9382220-B2 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2016-07-05 | — | — | US | claimed |
| US-9174954-B2 | 3,7-diamino-10H-phenothiazine salts and their use | WISTA LABORATORIES LTD. (SG) | 2015-11-03 | — | — | US | claimed |
| US-20140221359-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | Wis Ta Laboratories Ltd. (SG) | 2014-08-07 | — | — | US | claimed |
| US-20130317012-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2013-11-28 | — | — | US | claimed |
| US-20110294795-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. | 2011-12-01 | — | — | US | claimed |
| US-7956183-B2 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2011-06-07 | — | — | US | claimed |
| US-20070129543-A1 | PROCESSES FOR PREPARING NOVEL METHYLENE BLUE DERIVATIVE | VERFICATION TECHNOLOGIES, INC. (US) | 2007-06-07 | — | — | US | claimed |
| EP-1709020-A2 | PROCESSES FOR PREPARING NOVEL METHYLENE BLUE DERIVATIVE | Verification Technologies, Inc (US) | 2006-10-11 | — | — | EP | claimed |
| WO-2005049561-A2 | PROCESSES FOR PREPARING NOVEL METHYLENE BLUE DERIVATIVE | VERIFICATION TECHNOLOGIES, INC. (US) | 2005-06-02 | — | — | WO | claimed |
| US-20050107607-A1 | Processes for preparing novel methylene blue derivative | VERIFICATION TECHNOLOGIES, INC. | 2005-05-19 | — | — | US | claimed |
| EP-4745659-A1 | REFLECTING DEVICE, MANUFACTURING METHOD FOR REFLECTING DEVICE, AND VEHICLE | BYD Company Limited (CN) | 2026-05-20 | — | — | EP | disclosed |
| US-7176308-B2 | Processes for preparing novel methylene blue derivative | VERIFICATION TECHNOLOGIES, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-4500687-A | GRAFT POLYMERIZING AN EPOXY MONOMER AND AN ADDITION POLYMERIZABLE MONOMER | THE DOW CHEMICAL COMPANY (US) | 1985-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190131549-A1 | METAL COMPLEXES | AP1M1, AP2M1, APOL1 | SNCA 1654/4885NOX1 62/4885CAPN9 4173/4885 |
| US-20140221359-A1 | 3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | SNCA 517/4885NOX1 182/4885CAPN9 126/4885 |
| US-10700295-B2 | Metal complexes | AP1M1, AP2M1, APOL1 | SNCA 1654/4885NOX1 62/4885CAPN9 4173/4885 |
| US-20070129543-A1 | PROCESSES FOR PREPARING NOVEL METHYLENE BLUE DERIVATIVE | MB, HMBS, KIT | SNCA 266/4885NOX1 3596/4885CAPN9 1355/4885 |
| US-20130317012-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MAPT, TPMT, UROD | SNCA 227/4885NOX1 4259/4885CAPN9 1673/4885 |
| US-20050107607-A1 | Processes for preparing novel methylene blue derivative | MB, HMBS, KIT | SNCA 266/4885NOX1 3596/4885CAPN9 1355/4885 |
| US-20110294795-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MMAB, MB, ABCB7 | SNCA 1425/4885NOX1 3149/4885CAPN9 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.